Stock Spotlight Archives - Page 132 of 388

ThursdayFeb 17, 2022 2:37 pm

QualityStocksNewsBreaks – Laredo Oil Inc. (LRDC) Eyes Field’s Potential on Heels of Favorable Report for First Identified Wells at Montana Asset

Laredo Oil (OTC: LRDC) is an oil and gas exploration and production (“E&P”) company focused on acquiring, developing and operating conventional oil and gas properties. During a recent down cycle, the company leased 23,739 mineral acres in the Western Williston Basin of Montana at favorable prices and continues to make progress toward developing the asset. “In November, Laredo announced receiving a reserve report from an independent petroleum engineering firm estimating that interests attributable to certain properties in the Western Williston Basin of Montana acquired by Laredo subsidiary Lustre Oil Company LLC have a present total worth of ‘$41 million of…

ThursdayFeb 17, 2022 2:18 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Focused on Monetization, Building Scale on Heels of Major Accomplishments

Friendable (OTC: FDBL) is a mobile technology and marketing company focused on the development and identification of products, services and brand opportunities with mass-market potential and scalability. The company achieved significant milestones in 2021,including the release of a new Fan Pass Live on popular mobile app stores, as well as a new website version. The momentum continues in 2022 with the company’s acquisition of Artist Republik, a 360-degree platform for independent artists. Paired with Friendable’s flagship offering, the Fan Pass Live artist streaming platform, Artist Republik adds close to 100,000 new artists and triples the technology deck between the two…

WednesdayFeb 16, 2022 3:18 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc.’s (CSE: RWB) (OTCQX: RWBYF) Warren Facility Providing Centralized Distribution, Production Capacity to Expand Sales

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has received full licensing for manufacturing both medical and adult-use cannabis products in Michigan, a state entering its third year under legislation allowing the legal sale of adult recreational-use cannabis. In addition, a recent article notes, “The company has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in Warren, Michigan, which is part of RWB’s strategic planned acquisition of 18 Michigan dispensaries, four cultivation facilities and other significant real estate announced in September.” RWB CEO and Chairman Brad Rogers comments: “This Warren facility allows us to…

TuesdayFeb 15, 2022 3:19 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) Distinctive with Phased Approach to Novel Therapeutics Development

Mydecine (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, was featured in a recent Bell2Bell Podcast episode in which its co-founder, chairman and CEO Josh Bartch shared the company’s goals for the new year. Of note was Mydecine’s phased approach, which entails understanding the imperfections of initial formulations and then improving aspects such as the nature of half-life, controllability delivery time, onset time, anxiety associated with different molecules, etc., in order to make them more effective. This approach has set the company apart from its peers. A…

TuesdayFeb 15, 2022 12:46 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Closes Strategic Investment, Setting Stage for International Growth, Further Collaboration

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) today announced that it has closed a strategic investment from Nurture Healthy Food LLP, a wholly owned subsidiary of Nurture Capital LLC, on a non-brokered private placement basis for gross proceeds of $5,017,999.50. Per the strategic investment, the company issued 6,690,666 units, each at a price of $0.75, with each unit comprised of one common share of the company and one half of one common share purchase warrant at an exercise price of $1.00 per share, exercisable for 36 months after closing of the offering. “Our partnerships form an integral component of…

MondayFeb 14, 2022 2:22 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies

InMed Pharmaceuticals (NASDAQ: INM) understands the immense potential of rare cannabinoids and sees them as having applications as wide as cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), variants of cannabinoids that make up most of the content in cannabis plants. Studies suggest that rare cannabinoids could offer more potent medical benefits than CBD and without the psychoactive attribute of THC, representing a huge market. “However, the industry wide problem has always been to obtain the production scales necessary for cost-effective commercialization of such compounds, while also ensuring the purity and consistency that can be difficult at even low volumes. The answer is…

MondayFeb 14, 2022 2:04 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Furthering Global Foothold as Leader in Plant-Based Wellness, Lifestyle Brands

Flora Growth Corp. (NASDAQ: FLGC) is expanding its cannabis-derived brand presence in Latin American countries. Its Mind Naturals skincare brand, built with premium CBD and other high-quality ingredients, will be distributing a portfolio of 12 products through its agreement with Walmart’s online marketplace and Coppel e-commerce outlets. Walmart and Coppel are leading retail chains in Mexico and Central America. A recent article quotes Flora Growth CEO Luis Merchan as saying, “This agreement represents our first foray into the Mexican market and furthers our global foothold as a leader in plant-based wellness and lifestyle brands… As the cannabis market continues its…

MondayFeb 14, 2022 1:51 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Working on Turning Psychedelics-to-Therapeutics(TM) Vision into Reality

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is on a mission to revolutionize mental health care. The company has developed key relationships with a network of world-class partners and internationally recognized scientists as it focuses on creating safe and effective therapeutics for patients to address a multitude of mental health issues. “The company is working on turning its Psychedelics to Therapeutics(TM) vision into reality by engineering drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders,” reads a recent article, which contains excerpts…

FridayFeb 11, 2022 2:24 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Attentive as Broad Federal Cannabis Decriminalization Agenda Gets off the Ground

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is closely watching the growing bipartisan support for federal cannabis reform. A recent article, which contains excerpts from a December 2021 write-up in the National Law Review (“NLR”), reads, “‘Long-anticipated federal cannabis reform may be on the horizon… In the last month, bipartisan governors and groups from both bodies of Congress have established support for cannabis policies that would reshape federal enforcement and set the stage for further state legalization.’ The article specifically noted the States Reform Act, which was introduced by South Carolina Representative Nancy Mace in November;…

FridayFeb 11, 2022 1:09 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) to Be Evaluated for Potential Treatment Options for Multiple Conditions

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Chris Bunka noted that Lexaria would continue to see significant milestones in utilizing its patented DehydraTECH drug delivery technology in 2022. “Calendar 2022 will continue to see significant milestones utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking… We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease and diabetes,” a recent article quotes Bunka as saying. Lexaria received independent review board approval, marking…

Site Search

Company Search

Category: Stock Spotlight